-
1
-
-
0033380993
-
Clinical pharmacokinetics of artemether and lumefantrine (Riamet®)
-
Lefèvre G, Thom sen MS. Clinical Pharmacokinetics of artemether and lumefantrine (Riamet). Clin Drug Invest 1999;18:467-80. (Pubitemid 30047534)
-
(1999)
Clinical Drug Investigation
, vol.18
, Issue.6
, pp. 467-480
-
-
Lefevre, G.1
Thomsen, M.S.2
-
2
-
-
0029843392
-
Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria
-
de Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996;52:818-36. (Pubitemid 26413293)
-
(1996)
Drugs
, vol.52
, Issue.6
, pp. 818-836
-
-
De Vries, P.J.1
Dien, T.K.2
-
3
-
-
0030786432
-
Pharmacokinetics and bioavailability of oral and intramuscular artemether
-
DOI 10.1007/s002280050295
-
Karbwang J, Na-Bangchang K, Congpuong K, Molunto P, Thanavibul A. Pharmacokinetics and bioavailability of oral and intramuscular artemether. Eur J Clin Pharmacol 1997;52:307-10. (Pubitemid 27283299)
-
(1997)
European Journal of Clinical Pharmacology
, vol.52
, Issue.4
, pp. 307-310
-
-
Karbwang, J.1
Na-Bangchang, K.2
Congpuong, K.3
Molunto, P.4
Thanavibul, A.5
-
4
-
-
7244232725
-
Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria
-
DOI 10.1128/AAC.48.11.4234-4239.2004
-
Hien TT, Davis TM, Chuong LV, Ilett KF, Sinh DX, Phu NH et al. Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob Agents Chemother 2004;48:4234-9. (Pubitemid 39434880)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.11
, pp. 4234-4239
-
-
Hien, T.T.1
Davis, T.M.E.2
Chuong, L.V.3
Ilett, K.F.4
Sinh, D.X.T.5
Phu, N.H.6
Agus, C.7
Chiswell, G.M.8
White, N.J.9
Farrar, J.10
-
5
-
-
0031911977
-
The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats
-
Li G, Peggins JO, Fleckenstein LL, Masonic K, Heiffer MH, Brewer TG. Pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 1998;50:173-82. (Pubitemid 28102574)
-
(1998)
Journal of Pharmacy and Pharmacology
, vol.50
, Issue.2
, pp. 173-182
-
-
Li, Q.-G.1
Peggins, J.O.2
Fleckenstein, L.L.3
Masonic, K.4
Heiffer, M.H.5
Brewer, T.G.6
-
6
-
-
0036533251
-
Preparation of β-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice
-
DOI 10.1016/S0731-7085(01)00611-2, PII S0731708501006112
-
Chimanuka B, Gab riels M, Detaevernier MR, Plaizier-Vercammen JA. Preparation of b-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitemia in Plasmodium chabaudi malaria-infected mice. J Pharm Biomed Anal 2002;28:13-22. (Pubitemid 34171642)
-
(2002)
Journal of Pharmaceutical and Biomedical Analysis
, vol.28
, Issue.1
, pp. 13-22
-
-
Chimanuka, B.1
Gabriels, M.2
Detaevernier, M.-R.3
Plaizier-Vercammen, J.A.4
-
7
-
-
54049119962
-
Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether
-
Joshi M, Pathak S, Sharma S, Patravale V. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject Int J Pharm 2008;364:119-26.
-
(2008)
Nanoject Int J Pharm
, vol.364
, pp. 119-126
-
-
Joshi, M.1
Pathak, S.2
Sharma, S.3
Patravale, V.4
-
8
-
-
0034614208
-
Microemulsion-based media as novel drug delivery systems
-
Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89-121.
-
(2000)
Adv Drug Deliv Rev
, vol.45
, pp. 89-121
-
-
Lawrence, M.J.1
Rees, G.D.2
-
10
-
-
33645345962
-
Intranasal mucoadhesive microemulsions of clonazepam: Preliminary studies on brain targeting
-
Vyas TK, Babbar AK, Sharma RK, Singh S, Misra A. Intranasal mucoadhesive microemulsions of clonazepam: Preliminary studies on brain targeting. J Pharm Sci 2006;95:570-80.
-
(2006)
J Pharm Sci
, vol.95
, pp. 570-580
-
-
Vyas, T.K.1
Babbar, A.K.2
Sharma, R.K.3
Singh, S.4
Misra, A.5
-
11
-
-
41349090991
-
Parenteral microemulsions: An overview
-
Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int J Pharm 2008;355:19-30.
-
(2008)
Int J Pharm
, vol.355
, pp. 19-30
-
-
Date, A.A.1
Nagarsenker, M.S.2
-
12
-
-
33846649545
-
Validated HPTLC method of analysis for artemether and its formulations
-
DOI 10.1016/j.jpba.2006.08.029, PII S0731708506006078
-
Tayade NG, Nagarsenker MS. Validated HPTLC method of analysis for artemether and its formulations. J Pharm Biomed Anal 2007;43:839-44. (Pubitemid 46185786)
-
(2007)
Journal of Pharmaceutical and Biomedical Analysis
, vol.43
, Issue.3
, pp. 839-844
-
-
Tayade, N.G.1
Nagarsenker, M.S.2
-
13
-
-
1242337285
-
Solubilizing Excipients in Oral and Injectable Formulations
-
DOI 10.1023/B:PHAM.0000016235.32639.23
-
Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201-30. (Pubitemid 38221966)
-
(2004)
Pharmaceutical Research
, vol.21
, Issue.2
, pp. 201-230
-
-
Strickley, R.G.1
-
14
-
-
41349103477
-
Formulation and characterization of microemulsions of artemether for parenteral use
-
USA, Abstract No. 1210
-
Tayade NG, Nagarsenker MS. Formulation and characterization of microemulsions of artemether for parenteral use. In: Proceedings, AAPS Annual Meet and Exposition, USA, Abstract No. 1210 (2004).
-
(2004)
Proceedings, AAPS Annual Meet and Exposition
-
-
Tayade, N.G.1
Nagarsenker, M.S.2
-
15
-
-
19044386704
-
Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: Evaluation of accelerated and long-term stability
-
DOI 10.1016/S0939-6411(02)00057-7, PII S0939641102000577
-
Jumaa M, Mueller BW. Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: Evaluation of accelerated and long-term stability. Eur J Pharm Biopharm 2002;54:207-212. (Pubitemid 34919395)
-
(2002)
European Journal of Pharmaceutics and Biopharmaceutics
, vol.54
, Issue.2
, pp. 207-212
-
-
Jumaa, M.1
Muller, B.W.2
|